According to a Stage III clinical research published online in Epilepsia.

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy UCB today announced that the antiepileptic medication Vimpat – demonstrated significantly fewer partial-starting point seizures versus placebo in adults coping with epilepsy, according to a Stage III clinical research published online in Epilepsia. This study was among three that backed the authorization of Vimpat by the U tadacipla.com .S. Food and Drug Administration in 2008 for use as an add-on therapy for the treating partial-beginning point seizures in people with epilepsy who are 17 years and older.